ProGel
ProGel is an Australian biotechnology company that develops and licenses calcium alginate microgel encapsulation technology, producing sub-100 micron particles for food, pharmaceutical, and nutraceutical applications. It operates as a subsidiary of PERKii.
- Company typePrivate
- Founded2009
- HeadquartersBrisbane, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ProGel does
ProGel (Progel Pty. Ltd.) is an Australian biotechnology company headquartered in Brisbane that develops and licenses calcium alginate microgel encapsulation technology for the food, nutraceutical, pharmaceutical, agriculture, and chemical industries. The company's core platform produces sub-100 micron particles via a continuous one-step process with no moving parts, using only GRAS (Generally Recognized As Safe) food-grade ingredients. Functional capabilities include gastric protection of sensitive actives (proteins, enzymes, probiotics), controlled intestinal release triggered by elevated pH, taste masking of bitter compounds, and stabilization of lipids and lipophilic actives such as omega-3 fatty acids. A crossover clinical trial has demonstrated 50% higher DHA and EPA absorption, and taste masking has been validated across animal and human models.
ProGel firmographics
Firmographics- Name
- ProGel
- Legal name
- Progel Pty. Ltd.
- Website
- https://progel.com.au
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ProGel is an Australian biotechnology company that develops and licenses calcium alginate microgel encapsulation technology, producing sub-100 micron particles for food, pharmaceutical, and nutraceutical applications. It operates as a subsidiary of PERKii.
- Ownership category
- akta.pro rank
ProGel industry classification
Industry- Product category
- Microencapsulation Technology Services
- akta.pro primary industry
- Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)
- akta.pro secondary industries
- Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE), Probiotic/Prebiotic Functional Beverage Production (Non-Fermented) (AFAFAFAE), Probiotic & Live-Culture Beverage Production (Shots, Tonics) (AFAFAHAE)
Keywords
Where ProGel is headquartered
LocationHeadquarters
- HQ city
- Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
ProGel business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Technology Licensing and Collaboration Services: ProGel generates revenue through collaborative technology licensing arrangements with industry partners. Engagements involve proof-of-concept work followed by commercial implementation. Typical early-stage proof-of-concept projects take 1-2 months to complete.
- Professional Services and R&D Collaboration: Custom research and development services are provided to solve specific encapsulation challenges for pharmaceutical, food, supplements, agriculture and chemical companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
ProGel product offering
Product offeringCore offering
ProGel specialises in large-scale manufacturing of alginate microgels based on a calcium alginate gel system, producing tuneable particles under 100 microns for applications in food, nutraceuticals, and pharmaceuticals. The company commercialises this proprietary one-step continuous encapsulation technology through licensing arrangements and collaborative R&D services with industry partners, and demonstrates the technology through its PERKii probiotic beverage sub-brand.
Product overview
ProGel offers an industrial-scale microgel encapsulation platform technology based on calcium alginate gel systems. The core product is the Progel Microgel Encapsulation Technology, which produces tunable particles under 100 microns for food, pharmaceutical, and nutraceutical applications. The company also commercializes the technology through its subsidiary brand PERKii (launched 2016), a probiotic beverage product line that demonstrates the technology's application in functional foods. The Progel technology and PERKii brand together represent the company's product portfolio spanning both B2B encapsulation services and consumer-facing functional food products.
Differentiator
Problem solved
Functional benefit
Brands
- PERKii: Probiotic beverage brand launched in 2016 that utilises ProGel's encapsulation technology to deliver probiotic microorganisms in a fruit-flavoured, non-dairy, lactose, gluten and added sugar free carrier.
Products and services
- Progel Microgel Encapsulation Technology Industrial-scale calcium alginate microgel manufacturing platform producing tuneable particles under 100 microns for encapsulation applications in food, nutraceuticals, and pharmaceuticals. The technology enables gastric protection of sensitive actives, controlled intestinal release, taste masking of bitter compounds, enhanced probiotic viability, and lipid stabilization. Offered to enterprises through collaborative licensing and proof-of-concept engagements.
- PERKii Probiotic Beverage Probiotic beverage sub-brand launched in 2016 that utilises ProGel's microencapsulation technology to deliver Lactobacillus casei and Bifidobacterium strains in a fruit-flavoured, non-dairy, lactose-free, gluten-free format with extended shelf viability and no added sugar.
Quantifiable outcome
- 50% higher DHA and EPA absorption in crossover clinical trial with healthy adults
- +4 more outcomes
Companies that use ProGel
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles5 records
ProGel technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
ProGel partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- University of QueenslandcoreProGel is a spinout company of The University of Queensland, founded in 2009 to commercialize encapsulation technology developed by Professor Bhesh Bhandari and his associates. ProGel maintains a close relationship with UQ and utilizes top-tier research facilities including microbiology, sensory, and formulation laboratories.
- PERKiiflagshipPERKii is the parent company of ProGel and utilizes ProGel's encapsulation technology in its probiotic beverages. PERKii launched in 2016 and incorporates ProGel's microgel technology to deliver live probiotics in fruit-flavoured, non-dairy beverages. ProGel is now a subsidiary of PERKii.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
ProGel competitors and assessment
Company assessmentBroad incumbents
- Capsugel (Lonza): Lonza's capsule and oral-delivery business offering encapsulation, modified-release, and bioavailability-enhancement platforms used by pharma and nutraceutical customers globally.
- Kerry Group: Ireland-headquartered taste and nutrition company providing encapsulation, probiotic delivery, and bioavailability solutions to F&B and pharma customers — directly overlapping ProGel's food and nutraceutical applications.
- Ingredion Incorporated: US-listed ingredient solutions provider with encapsulation and stabilization technologies for functional food, beverage, and supplement customers — overlapping ProGel's stability and bioavailability applications.
- DSM-Firmenich: Global nutrition and health major offering encapsulated vitamins, omega-3s, probiotics, and taste-masking solutions. Represents the large-scale incumbent that ProGel positions against in food, nutraceutical, and pharma encapsulation.
- Evonik Industries: German specialty chemicals company with a healthcare delivery systems business offering oral and parenteral drug delivery, lipid-based carriers, and taste-masking — comparable to ProGel's pharma encapsulation use cases.
- Givaudan: Global flavor and taste-solutions leader with extensive encapsulation and taste-masking capabilities for food, beverage, and pharma applications — overlapping with ProGel's taste-masking and controlled-release use cases.
- Balchem Corporation: US-listed specialty ingredient company with a substantial encapsulation platform serving food, nutrition, and pharma customers with targeted-release and protection technologies overlapping ProGel's value proposition.
- Chr. Hansen (Novonesis): Global microbial and fermentation powerhouse (now merged with Novozymes) supplying probiotic cultures, enzymes, and bioactive delivery solutions to food, supplement, and agriculture customers — comparable to ProGel's probiotic and animal-feed applications.
Emerging players
- BioGaia AB: Sweden-listed probiotics specialist that develops and licenses probiotic strains for food supplements and infant formula — overlapping ProGel's probiotic encapsulation and PERKii-adjacent application space.
Direct peers
- AnaBio Technologies: Ireland-based microencapsulation technology company offering alginate and polymer-based delivery systems for probiotics, bioactives, and pharmaceuticals. Closest comparable in scale and technology category to ProGel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ProGel social profiles
Digital presenceProGel financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProGel leadership team
Management profileNumber of profiles
Profiles4 records
ProGel funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProGel M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProGel
What does ProGel do?
ProGel specialises in large-scale manufacturing of alginate microgels based on a calcium alginate gel system, producing tuneable particles under 100 microns for applications in food, nutraceuticals, and pharmaceuticals. The company commercialises this proprietary one-step continuous encapsulation technology through licensing arrangements and collaborative R&D services with industry partners, and demonstrates the technology through its PERKii probiotic beverage sub-brand.
Is ProGel a public or private company?
ProGel is a private company. It is classified as corporate owned and is currently operating.
When was ProGel founded?
ProGel was founded in 2009. It employs 11 to 50 people.
Where is ProGel based?
ProGel is headquartered in Brisbane, Australia, in the Oceania region.
How does ProGel make money?
Two revenue lines are on record. Technology Licensing and Collaboration Services are the primary driver. The others are professional Services and R&D Collaboration.
Who are ProGel's main competitors?
Broad incumbents on record are Capsugel (Lonza), Kerry Group, Ingredion Incorporated, DSM-Firmenich, Evonik Industries, Givaudan, Balchem Corporation and Chr. Hansen (Novonesis). BioGaia AB is listed as an emerging player. AnaBio Technologies is listed as a direct peer.
Does ProGel have an API?
No public API is recorded for ProGel.
What industry is ProGel in?
ProGel's product category is Microencapsulation Technology Services. Its primary akta.pro industry code is HLAAAFAJ, Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery), with a secondary code of AFAJAJAE, Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases).